Filing Flows › Comparisons › NTRA vs GH
Natera vs Guardant Health: NTRA and GH compared
Natera is the larger company: $794M of revenue in its latest quarter (Q3 2026) against $361M for Guardant Health (Q3 2026). Guardant Health is growing faster (+36% against +34% a year earlier). Natera is more profitable, with an operating margin of -8.6% against -36.8%.
Where the money goes: NTRA and GH
Natera (NTRA) · Q3 2026
Natera, Q3 2026: revenue $794M (+34% year over year), operating margin -8.6%, net loss $59.9M, operating cash flow $43.9M. The chart follows the revenue to costs, profit and cash.
Guardant Health (GH) · Q3 2026
Guardant Health, Q3 2026: revenue $361M (+36% year over year), operating margin -36.8%, net loss $124M, operating cash flow −$23.7M. The chart follows the revenue to costs, profit and cash.
| Natera (NTRA) | Guardant Health (GH) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $794M | $361M |
| Revenue growth, Y/Y | +34% | +36% |
| Operating margin | -8.6% | -36.8% |
| Net earnings | −$59.9M | −$124M |
| Net margin | -7.5% | -34.5% |
| Operating cash flow | $43.9M | −$23.7M |
| Free cash flow | $5.3M | — |
| Market value | $44.8B | $20.3B |
| Analysts’ mean target | $416.39 | $200.84 |
Where the revenue comes from
Natera
- Product revenues: $790M (99%)
- Licensing and other revenues: $4.0M (1%)
Guardant Health
- Oncology: $231M (64%)
- Screening: $67.6M (19%)
- Biopharma and data: $59.0M (16%)
- Licensing and other: $3.1M (1%)
Questions
Which is bigger, Natera or Guardant Health?
Natera is the larger company: $794M of revenue in its latest quarter (Q3 2026) against $361M for Guardant Health (Q3 2026).
Is Natera or Guardant Health growing faster?
Guardant Health is growing faster (+36% against +34% a year earlier).
Which is more profitable, Natera or Guardant Health?
Natera is more profitable, with an operating margin of -8.6% against -36.8%.
More: Natera earnings · how Natera makes money · Guardant Health earnings · how Guardant Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.